Purpose
to determine long-term immunogenicity and protective efficacy of a leading CoV2 vaccine produced in insect cells, co-administered with either a saponin-based adjuvant (Matrix M)
Grantee
Division
Global Health
Date
SEPTEMBER 2020
Region served
GLOBAL
Committed amount
$2,365,494
Grant topic
Discovery and Translational Sciences
Duration (months)
47
Grantee location
Huddinge, AB, Sweden
Program strategy page
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.